Inclusion body myositis

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

7 events
Sep 2025The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

LMU Klinikum — NA

TrialENROLLING BY INVITATION
May 2025Ruxolitinib Treatment in Inclusion Body Myositis

Assistance Publique - Hôpitaux de Paris — PHASE2

TrialRECRUITING
Oct 2024Long-term Extension Study of Ulviprubart (ABC008) in Subjects With Inclusion Body Myositis

Abcuro, Inc. — PHASE2, PHASE3

TrialACTIVE NOT RECRUITING
Aug 2024Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis

Austin Neuromuscular Center — EARLY_PHASE1

TrialRECRUITING
Nov 2023Monitoring Biomarker for Detecting Change in Physical Activity and Limb Function in Inclusion Body Myositis Over Time

University of Kansas Medical Center

TrialACTIVE NOT RECRUITING
Jul 2022Phase III Trial of Sirolimus in IBM

University of Kansas Medical Center — PHASE3

TrialACTIVE NOT RECRUITING
Oct 2021Sporadic Inclusion Body Myositis Natural History Study

University of California, Irvine

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Inclusion body myositis.
Check the disease page for updates →

Clinical Trial Landscape

7 active trials
1Phase 3
1Phase 2
1N/A
2Unknown
1EARLY_PHASE1
1PHASE2, PHASE3
7Total recruiting
Search clinical trials for Inclusion body myositis

Recent News & Research

No recent news articles indexed yet for Inclusion body myositis.
Search PubMed for Inclusion body myositis

Browse all Inclusion body myositis news →

Specialist Network

Top 6 by expertise

View all Inclusion body myositis specialists →

Quick Actions